Á lódáil...
Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study
BACKGROUND: COVID-19 characterized by refractory hypoxemia increases patient mortality because of immunosuppression effects. This study aimed to evaluate the efficacy of immunomodulatory with thymosin α1 for critical COVID-19 patients. METHODS: This multicenter retrospective cohort study was perform...
Na minha lista:
| Foilsithe in: | Int Immunopharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Elsevier B.V.
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7409727/ https://ncbi.nlm.nih.gov/pubmed/32795897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.106873 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|